Amdocs (NASDAQ:DOX) Releases FY 2026 Earnings Guidance

Amdocs (NASDAQ:DOXGet Free Report) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 7.340-7.480 for the period, compared to the consensus estimate of 7.310. The company issued revenue guidance of $4.6 billion-$4.7 billion, compared to the consensus revenue estimate of $4.7 billion. Amdocs also updated its Q3 2026 guidance to 1.810-1.870 EPS.

Analysts Set New Price Targets

Several research firms have recently weighed in on DOX. Stifel Nicolaus cut their price target on shares of Amdocs from $97.00 to $88.00 and set a “buy” rating for the company in a report on Wednesday, February 4th. Wall Street Zen raised shares of Amdocs from a “hold” rating to a “buy” rating in a report on Saturday, April 18th. Weiss Ratings reissued a “hold (c-)” rating on shares of Amdocs in a report on Friday. Finally, Barclays cut their price target on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a report on Wednesday, February 4th. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $92.33.

View Our Latest Stock Analysis on DOX

Amdocs Trading Down 3.9%

Shares of DOX traded down $2.41 during mid-day trading on Wednesday, reaching $59.93. The stock had a trading volume of 1,810,046 shares, compared to its average volume of 1,226,916. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.06 and a quick ratio of 1.06. Amdocs has a 52-week low of $59.40 and a 52-week high of $95.41. The business’s fifty day moving average is $65.71 and its 200 day moving average is $73.96. The firm has a market cap of $6.47 billion, a price-to-earnings ratio of 11.59, a P/E/G ratio of 1.11 and a beta of 0.40.

Key Headlines Impacting Amdocs

Here are the key news stories impacting Amdocs this week:

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of DOX. WealthCollab LLC lifted its position in Amdocs by 94.5% in the third quarter. WealthCollab LLC now owns 356 shares of the technology company’s stock valued at $29,000 after buying an additional 173 shares during the last quarter. Los Angeles Capital Management LLC acquired a new stake in shares of Amdocs during the fourth quarter worth about $39,000. Advisory Services Network LLC acquired a new stake in shares of Amdocs during the third quarter worth about $42,000. CIBC Private Wealth Group LLC lifted its position in shares of Amdocs by 190.2% during the third quarter. CIBC Private Wealth Group LLC now owns 595 shares of the technology company’s stock worth $49,000 after purchasing an additional 390 shares in the last quarter. Finally, Transamerica Financial Advisors LLC lifted its position in shares of Amdocs by 146.5% during the fourth quarter. Transamerica Financial Advisors LLC now owns 668 shares of the technology company’s stock worth $54,000 after purchasing an additional 397 shares in the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.

About Amdocs

(Get Free Report)

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.

Recommended Stories

Earnings History and Estimates for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.